Covaxin to cost Rs 1,200 per dose for private hospitals, Rs 600 for states
Bharat Biotech noted that the manufacturing process was expensive due to low process yields, and that it was important to recover costs to invest in future R&D
Bharat Biotech noted that the manufacturing process was expensive due to low process yields, and that it was important to recover costs to invest in future R&D https://ift.tt/3erKVDM April 24, 2021 at 07:24AM
Bharat Biotech noted that the manufacturing process was expensive due to low process yields, and that it was important to recover costs to invest in future R&D https://ift.tt/3erKVDM April 24, 2021 at 07:24AM
Comments
Post a Comment